MyFinsight
Home
Blog
About
Income Statement
|
Cash Flow
|
Balance Sheet
|
Ratios
Income Overview
Revenue
$59,425K
Net Income
-$1,175K
Net Profit Margin
-1.98%
EPS
-$0.08
Unit: Thousand (K) dollars
Revenue Breakdown
Pharmacology Services
Product And Service Other
Translational Oncology Solutions...
Subscribe for Financial Insights
Page 1
Annual
123
Page 1
Income Statement
2026-04-30
Oncology revenue
59,425
Cost of oncology revenue
30,900
Research and development
9,084
Sales and marketing
9,318
General and administrative
11,152
Loss on disposal of equipment
-111
Total costs and operating expenses
60,565
Income (loss) from operations
-1,140
Other income, net
211
Income (loss) before income tax expense
-929
Provision (benefit) for income tax
246
Net income (loss)
-1,175
Basic EPS
-0.08
Diluted EPS
-0.08
Basic Average Shares
13,832,385
Diluted Average Shares
13,832,385
Page 1
Unit: Thousand (K) dollars (except for numbers of shares and EPS).
Page 1
Buy us a coffee
Time Plot
Show the time plot by selecting a row from the table.
Income Statement
Net income (loss)
-$1,175K
Income (loss) before
income tax expense
-$929K
Provision (benefit) for
income tax
$246K
Other income, net
$211K
Pharmacology Services
$57,133K
Product And Service
Other
$1,528K
Translational Oncology
Solutions TOSLicense...
$764K
Income (loss) from
operations
-$1,140K
Oncology revenue
$59,425K
Total costs and
operating expenses
$60,565K
Cost of oncology
revenue
$30,900K
General and
administrative
$11,152K
Sales and marketing
$9,318K
Research and development
$9,084K
Loss on disposal of
equipment
-$111K
Buy us a coffee
CHAMPIONS ONCOLOGY, INC. (CSBR)
CHAMPIONS ONCOLOGY, INC. (CSBR)